Blood cancers

Children with relapsed leukaemia may benefit from second HSCT

Children with acute leukaemia who relapse after haemopoietic stem cell transplantation (HSCT) may benefit from a second transplantation, a multinational study shows. A second HSCT is most likely to have a successful outcome in younger children with a low disease burden, according to a study of 251 children and adolescents (median age 11 years) with ...

Already a member?

Login to keep reading.

© 2021 the limbic